1. Overview of the Conference Presentation and Brightening Treatment Paradigm

Dr. Shin Yong-bae, Director of Dr. Newcell Clinic, will present a new brightening booster treatment strategy utilizing tranexamic acid (TXA) and madecassoside at the 51st Autumn International Scientific Congress of the Korean Academy of Laser Dermatology and Trichology (KALDAT), held in Seoul on December 14.

This lecture will systematically outline the brightening pathway, in which pigmentation, inflammation, and skin barrier function interact in a complex manner, and will focus on treatment workflows that can be practically applied in clinical settings.

Dr. Shin explains that brightening should not be viewed simply as improving skin brightness, but as a comprehensive therapeutic process involving inhibition of pigmentation signals, inflammation control, stabilization of the skin barrier, oxidative stress management, regulation of cellular turnover, and soothing effects. The lecture will also present clinical cases demonstrating the synergistic benefits of combining TXA and madecassoside.

2. Clinical Application and Procedural Use of the Brightening Skin Booster ‘ELREJU’

The presentation will also include clinical application experience with the brightening skin booster “ELREJU.” This formulation combines TXA and madecassoside with PN, PDRN, succinic acid, and hybrid hyaluronic acid.

ELREJU is designed to integrate brightening, hydration, and skin regeneration into a single therapeutic process. The lecture will highlight its enhanced absorption efficiency when used in combination with MTS or laser devices, as well as clinical cases demonstrating improved skin balance and recovery, emphasizing its practical utility in real clinical procedures.

3. FDA Approval and the Future Perspectives of Combination Brightening Therapies

Meanwhile, ELREJU has attracted growing attention after receiving approval from the U.S. Food and Drug Administration (FDA), highlighting its technical stability and clinical applicability as a multi-component brightening formula.

As demand increases for products that meet international standards and discussions around advanced brightening treatments continue to expand, ELREJU is gaining recognition as a validated treatment option.

Dr. Shin stated, “Brightening cannot be effectively achieved through a single ingredient or pathway alone. A comprehensive approach considering multiple biological signals is essential. We will continue to develop treatment strategies based on clinical data to restore skin clarity and balance.